Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Teniposide is a topoisomerase II poison.1,2,3,4 It promotes calf thymus topoisomerase II-mediated DNA cleavage when used at concentrations ranging from 0.04 to 40 µg/ml.1 Teniposide induces single- and double-stranded DNA breaks in a concentration-dependent manner.2 It inhibits the proliferation of A549 lung cancer cells (IC50 = 0.7 µM). Teniposide induces cell cycle arrest at the S phase and apoptosis in Tca8113 tongue squamous cell carcinoma cells when used at a concentration of 5 mg/L and induces cell cycle arrest at the G2/M phase when used at 0.15 mg/L.3 It reduces tumor growth and inhibits metastasis in a 3LL murine Lewis lung carcinoma model when administered at a dose of 6.5 mg/kg.4 Formulations containing teniposide have been used in combination therapy in the treatment of refractory childhood acute lymphoblastic leukemia.
WARNING This product is not for human or veterinary use.
1. Role of topoisomerase II in mediating epipodophyllotoxin-
2. Single-
3. Topoisomerase II trapping agent teniposide induces apoptosis and G2/M or S phase arrest of oral squamous cell carcinoma. World J. Surg. Oncol. 4(1), 41 (2006).
4. Comparison between VP 16 and VM 26 in Lewis lung carcinoma of the mouse. Eur. J. Cancer Clin. Oncol. 22(2), 173-179 (1986).